The Benefit of the Intervention of Clowns in Pediatric Oncology in the Accompaniment of Painful Acts (ICOD)

March 11, 2022 updated by: Madame Valérie GAÜZES, Central Hospital, Nancy, France

Study on the Benefit of the Intervention of Clowns in Pediatric Oncology in the Accompaniment of Painful Acts

The diagnosis and treatment of childhood cancer involves frequent and repeated painful acts. The pediatric oncology-hematology service of Nancy's hospital innovates thanks to the involvement of clowns in the hospital. The effects of the clown's intervention corroborate the results of studies which demonstrate that when painful complaints are increased by an empathetic attitude, they are reduced by half when the child is distracted.

The main objective is to assess the impact of the presence or absence of clowns during the performance of a painful act, on pain, in children who have benefited from this act. no clowns during the performance of a painful act, on anxiety, in children who have benefited from this act.

The secondary objectives are:

  • Evaluate the impact of the presence or not of clowns during the performance of a painful act, on the anxiety of the parents of the child who benefited from this act.
  • Measure the perception and acceptance of the healthcare team of the presence of clowns 1 time every 3 months.
  • Measure the clowns' perception of their interaction with the child, the parents and the healthcare team once every 3 months.
  • Evaluate the overall impact of the clown intervention during the performance of a painful act in children on the course of the act by a "neutral" person (health manager) once every 3 months.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

74

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Nancy, France, 54035
        • Recruiting
        • CHRU de Nancy
        • Contact:
          • Valérie Gaüzes
        • Principal Investigator:
          • Valérie Gaüzes

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 years to 16 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Child virgin with experience for targeted acts during the 1st painful act or child undergoing follow-up provided that he is virgin with experience of the presence of clowns during these acts.
  • Child with cancer
  • Child requiring a painful act among the following 3 acts: lumbar puncture, myelogram, needle placement in an implantable chamber
  • Parental authority holder (s) who have received full information on the organization of the research and who have given their written consent for the participation of their child
  • Personal adhesion of the child with a view to his participation
  • Presence of at least one of the two parents during act 1
  • Availability of the duo of clowns for the realization of act n ° 1 if the group assigned is the group Clowns-Sans Clowns

Exclusion Criteria:

  • Parents / child's refusal of clowns to intervene

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
OTHER: Without Clowns - Clowns (WC-C)
Firstly a painful act without the presence of the clown duo, then in a second time the same painful act in the presence of the clown duo
presence or absence of clowns during the performance of a painful act, on pain
OTHER: Clowns- Without clowns (C-WC)
Firstly a painful act with the presence of the clown duo, then in a seconde time, the same painful act without the presence of the clown duo
presence or absence of clowns during the performance of a painful act, on pain

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Pain score of the patient Self Assessment Scale (VAS)
Time Frame: inclusion, up to 2 years
The scale is between 0 to 100
inclusion, up to 2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anxiety score of the patient with modified-Yale Preoperative Anxiety Scale (m-YPAS)
Time Frame: inclusion, up to 2 years
The scale is between 0 to 100 If the score is inferior to 24, the patient is considered relaxed If the score is superior to 24, the patient is considered anxious
inclusion, up to 2 years
Anxiety score of the patient with modified-Yale Preoperative Anxiety Scale (m-YPAS)
Time Frame: up to 8 weeks after inclusion
The scale is between 0 to 100 If the score is inferior to 24, the patient is considered relaxed If the score is superior to 24, the patient is considered anxious
up to 8 weeks after inclusion
Usual Anxiety score of the parents Questionnaire State-Trait Anxiety Inventory (STAI form Y-B)
Time Frame: inclusion, up to 2 years
The score is between 21 to 77 Score superior to 65 : very high anxiety Score between 56 to 65 : high anxiety Score between 46 to 55 : medium anxiety Score between 36 to 45 : low anxiety Score inferior to 35 : very low anxiety
inclusion, up to 2 years
Usual Anxiety score of the parents Questionnaire State-Trait Anxiety Inventory (STAI form Y-B)
Time Frame: up to 8 weeks after inclusion
The score is between 21 to 77 Score superior to 65 : very high anxiety Score between 56 to 65 : high anxiety Score between 46 to 55 : medium anxiety Score between 36 to 45 : low anxiety Score inferior to 35 : very low anxiety
up to 8 weeks after inclusion
Change of Anxiety score of the parents Questionnaire State-Trait Anxiety Inventory (STAI form Y-A)
Time Frame: inclusion, up to 2 years
The score is between 20 to 80 Score superior to 65 : very high anxiety Score between 56 to 65 : high anxiety Score between 46 to 55 : medium anxiety Score between 36 to 45 : low anxiety Score inferior to 35 : very low anxiety
inclusion, up to 2 years
Change of Anxiety score of the parents Questionnaire State-Trait Anxiety Inventory (STAI form Y-A)
Time Frame: up to 8 weeks after inclusion
The score is between 20 to 80 Score superior to 65 : very high anxiety Score between 56 to 65 : high anxiety Score between 46 to 55 : medium anxiety Score between 36 to 45 : low anxiety Score inferior to 35 : very low anxiety
up to 8 weeks after inclusion
Score of perception and acceptance of the presence of clowns with the healthcare team Questionnaire
Time Frame: through completion of the study, an average of 2 years
The questionnaire is composed by 19 questions The scale of each question is between 1 (not agree at all) to 4 (totally agree)
through completion of the study, an average of 2 years
Perception score of interactions with the child, parents and the team with clowns Questionnaire
Time Frame: through completion of the study, an average of 2 years
The questionnaire is composed by 12 questions The scale of each question is between 1 (not agree at all) to 4 (totally agree)
through completion of the study, an average of 2 years
Score of evaluation of the overall impact of the presence or not of a clown Questionnaire
Time Frame: through completion of the study, an average of 2 years
The observation gris is composed by 14 questions
through completion of the study, an average of 2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Pascal Chastagner, CHRU de Nancy

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 8, 2022

Primary Completion (ANTICIPATED)

April 8, 2024

Study Completion (ANTICIPATED)

October 8, 2024

Study Registration Dates

First Submitted

October 15, 2020

First Submitted That Met QC Criteria

January 24, 2022

First Posted (ACTUAL)

January 25, 2022

Study Record Updates

Last Update Posted (ACTUAL)

March 14, 2022

Last Update Submitted That Met QC Criteria

March 11, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2019-A03302-55

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on clowns

3
Subscribe